10
Participants
Start Date
June 1, 2018
Primary Completion Date
January 1, 2019
Study Completion Date
January 1, 2019
Glucagon-Like Peptide-2 (GLP-2)
Glucagon-Like Peptide-2 (GLP-2) injection.
Glucose-dependent insulinotropic polypeptide (GIP)
Glucose-dependent insulinotropic polypeptide (GIP) injection.
GLP-2+GIP
GLP-2+GIP injection.
Placebo
Placebo injection.
Hvidovre University Hospital, Hvidovre
Hvidovre University Hospital
OTHER
University of Copenhagen
OTHER